S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well lapatinib works in treating patients with locally
advanced or metastatic stomach cancer. Lapatinib may stop the growth of tumor cells by
blocking some of the enzymes needed for cell growth